A genetic and molecular approach to understanding allelic and phenotypic heterogeneity in Acrofacial dysostosis, Cincinnati-type
A genetic and molecular approach to understanding allelic and phenotypic heterogeneity in Acrofacial dysostosis, Cincinnati-type
批准号:
9913571
负责人:
Kathryn Nicole Weaver
金额:
$16.3万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-11 至 2022-03-31
关键词:
AblationAcrofacial DysostosisAffectAllelesAnimalsBasic ScienceBindingBiogenesisCardiacCardiac developmentCardiovascular systemCellsClinicalClinical ResearchComplexCongenital AbnormalityCongenital Heart DefectsCraniofacial AbnormalitiesDataDefectDevelopmentDiseaseEmbryoEnzymesGene ExpressionGeneticGenetic DiseasesGenetic StructuresGenetic TranscriptionGenetic TranslationGenomicsGoalsGrantHeartHeart AbnormalitiesHeterogeneityHumanIn VitroIncidenceInterventionLeadLive BirthMediatingMedical GeneticsMethodsModelingMolecularMolecular GeneticsMorbidity - disease rateMusMutationNeural Crest CellOutputPatent Ductus ArteriosusPathogenicityPathway interactionsPatientsPatternPhenotypePhysiciansPlayPolymerasePopulationPregnancyPrevalenceProcessProteinsPublishingRNA Polymerase IResearch PersonnelRibosomal DNARibosomesRoleScientistSeriesSeveritiesSyndromeTechniquesTestingTherapeutic InterventionTissuesTranslational RegulationTranslational ResearchTranslationsVariantVentricular Septal DefectsWorkZebrafishatrioventricular septal defectbasecohortconditional knockoutcongenital heart disorderdesignexperiencegenetic varianthuman modelin vivoinsightmalformationmortalitymouse modelnovelpleiotropismpreventprotein expressionribosome profilingskillsstem cellstranscriptome sequencing
中文摘要
摘要
先天性心脏病(CHD)是最常见的出生缺陷类型,患病率约为
1%的活产儿和广泛的发病率和死亡率。核糖体生物发生障碍
(“核糖体疾病”)是先天畸形综合征,与先天性心脏病和颅面部疾病有不同的相关性。
反常现象。破坏无处不在的过程(核糖体生物发生)导致组织-
特定的表型,如CHD尚不清楚。辛辛那提型颌面部骨质疏松症(AFD-CIN)是一种新近发现的
发现了由POLR1A突变引起的常染色体显性遗传性核糖体病。在我们的患者队列中
使用AFD-CIN,我们观察到CHD的发病率增加。此应用程序的目标是研究如何
POLR1A介导的核糖体生物发生扰动扰乱心脏发育,并确定
不同POLR1A等位基因组织特异性效应的机制。核心假设是,
POLR1A等位基因引起蛋白质表达的翻译调节的谱系特异性改变。我们将测试
这一假设有以下三个具体目的:[1]分析神经脊细胞对Polr1a的需求
和第二心域,[2]分析Polr1a等位基因系列的表型和功能,并[3]量化
不同Polr1a等位基因对核糖体生物发生和信使核糖核酸翻译的谱系特异性影响。方法将
包括[1]Polr1a条件敲除等位基因的详细表型,[2]在体外和体内产生的
(小鼠)人类突变的模型,以及[3]用RNA-seq评估Polr1a中断的组织特异性影响
和Ribo-Seq.通过完成这三个目标,我将获得独立的经验和技能
领导临床、转化和基础研究的研究员。成功完成这笔赠款的目标
将[1]确定核糖体生物发生在心脏发育中的作用,[2]确认POLR1A的致病性
小鼠的遗传变异,[3]提供了对POLR1A致病区域的洞察,并[4]阐明了新的
介导与Polr1a丢失相关的组织特异性表型的途径。总而言之,这可以使
干预以减轻甚至预防与核糖体生物发生缺陷相关的畸形。
英文摘要
ABSTRACT
Congenital heart defects (CHD) are the most common class of birth defects, with a prevalence of approximately
1% of live births and a wide range of morbidity and mortality. Disorders of ribosome biogenesis
(“ribosomopathies”) are congenital malformation syndromes variably associated with both CHD and craniofacial
anomalies. The mechanism by which disruption of a ubiquitous process (ribosome biogenesis) leads to tissue-
specific phenotypes such as CHD is unknown. Acrofacial dysostosis, Cincinnati type (AFD-CIN) is a recently
identified autosomal dominant ribosomopathy caused by mutations in POLR1A. Among our cohort of patients
with AFD-CIN we observed an increased incidence of CHD. The objective of this application is to study how
POLR1A-mediated perturbation of ribosome biogenesis disrupts cardiac development, and to determine the
mechanisms underlying tissue-specific effects of different POLR1A alleles. The central hypothesis is that distinct
POLR1A alleles cause lineage-specific alteration of translational regulation of protein expression. We will test
this hypothesis with the following three specific aims: [1] Analyze the requirement for Polr1a in neural crest cells
and the second heart field, [2] Analyze phenotype and function of an allelic series of Polr1a, and [3] Quantify
the lineage-specific effects of distinct Polr1a alleles on ribosome biogenesis and mRNA translation. Methods will
include [1] detailed phenotyping of conditional knock-out alleles of Polr1a, [2] generating in vitro and in vivo
(mouse) models of human mutations, and [3] assessing tissue-specific effects of Polr1a disruption with RNA-seq
and Ribo-Seq. Through completion of these three aims, I will gain experience and skills as an independent
investigator leading clinical, translational, and basic research. Successful completion of the goals of this grant
will [1] define a role for ribosome biogenesis in cardiac development, [2] confirm pathogenicity of POLR1A
genetic variants in mice, [3] provide insight into pathogenic domains of POLR1A, and [4] elucidate novel
pathways that mediate tissue-specific phenotypes associated with loss of Polr1a. Collectively this could enable
intervention to reduce severity or even prevent malformations associated with defects in ribosome biogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Contributions to Valvar Pulmonary Stenosis
-
批准号:10668443
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2022
-
负责人:Kathryn Nicole Weaver
-
依托单位:
Genetic Contributions to Valvar Pulmonary Stenosis
-
批准号:10452823
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2022
-
负责人:Kathryn Nicole Weaver
-
依托单位: